Medicine Description marsalaz 500 mg
marsalaz 30 tablets 500 mg is a medication that contains mesalamine, which is an aminosalicylate compound. The primary mechanism of action involves the topical application of mesalamine to the colonic mucosa, where it exerts anti-inflammatory effects. Mesalamine inhibits the production of pro-inflammatory cytokines and leukotrienes, which play a crucial role in the inflammatory pathway associated with ulcerative colitis. By blocking these inflammatory mediators, mesalamine helps to induce and maintain remission in patients suffering from this condition. Additionally, mesalamine may also scavenge free radicals and inhibit the activity of nuclear factor kappa B (NF-kB), further contributing to its anti-inflammatory properties.
Indications and Uses of marsalaz 30 tablets 500 mg
- Management of mild to moderate ulcerative colitis
- Prevention of recurrence of ulcerative colitis symptoms
Side Effects of marsalaz 30 tablets 500 mg
- Abdominal pain
- Nausea
- Diarrhea
- Headache
- Rash
- Fatigue
Storage and Handling
Store at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.
Patient Advice and Precautions
Patients should be advised to take Marsalaz with plenty of fluids to enhance efficacy and reduce gastrointestinal side effects. It is essential to inform healthcare providers of any existing or previous kidney issues, as mesalamine may affect renal function. Regular monitoring of renal function is recommended during treatment. If any severe side effects or allergic reactions occur, such as difficulty breathing or swelling, immediate medical attention is necessary.